Researchers testing anti-parasitic drug as COVID-19 treatment
The University of Oxford announced Wednesday that researchers are testing an anti-parasitic drug as a COVID-19 treatment.
In a statement, Oxford shared that the new trial will include the drug ivermectin, which it said has shown promising results as a potential treatment for coronavirus patients.
“Ivermectin is readily available globally, has been in wide use for many other infectious conditions so it’s a well-known medicine with a good safety profile, and because of the early promising results in some studies it is already being widely used to treat COVID-19 in several countries,” Oxford professor Chris Butler said in a statement.
“We hope to generate robust evidence to determine how effective the treatment is against COVID-19, and whether there are benefits or harms associated with its use,” he added.
The large-scale trial will examine the treatments of people who are more at risk of serious illness from COVID-19. The anti-parasitic drug is the seventh treatment to be tested in the trial.
The United Kingdom has been struggling to contain a strain of COVID-19 known as the delta variant, particularly in communities where vaccination rates are low.
Copyright 2023 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Regular the hill posts